Cancer Research UK logo.
SearchDonate
  • Search

A study looking at rucaparib for solid tumours including ovarian cancer

Overview

Cancer types:

All cancer types, Ovarian cancer, Secondary cancers

Status:

Results

Phase:

Phase 1/2

Details

This study looked at a drug called rucaparib for people who had solid tumours. It was for people whose cancer had grown into surrounding tissue or spread elsewhere in the body. This is locally advanced or advanced cancer.

are any type of cancer apart from blood cancers such as leukaemia. The trial included women who had cancer of the , fallopian tube cancer or primary peritoneal cancer. Doctors treat these cancers in the same way. So, when we use the term ovarian cancer in this summary, we are referring to all 3.

This study was open for people to join between 2011 and 2016. Some results were published in 2017 and some in 2018.

Recruitment start: 14 December 2011

Recruitment end: 30 June 2016

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Dr Rebecca Kristeleit

Supported by

Clovis Oncology Inc

Experimental Cancer Medicine Centre (ECMC)

NIHR Clinical Research Network: Cancer

Last reviewed: 22 Oct 2020

CRUK internal database number: 9376

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.